Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) on anemia in non-dialysis-dependent chronic kidney disease (NDD-CKD): a systematic review and meta-analysis

International Urology and Nephrology ◽

10.1007/s11255-020-02671-z ◽

2020 ◽

Author(s):

Siliang Zhang ◽

Jing Guo ◽

Shuqin Xie ◽

Jianwei Chen ◽

Shenrun Yu ◽

...

Keyword(s):

Systematic Review ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Meta Analysis ◽

Hypoxia Inducible Factor ◽

Prolyl Hydroxylase ◽

Efficacy And Safety ◽

Prolyl Hydroxylase Inhibitor

Download Full-text

Effectiveness of hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat on renal anemia in non-dialysis-dependent chronic kidney disease: a systematic review and meta-analysis

Annals of Translational Medicine ◽

10.21037/atm.2019.12.18 ◽

2019 ◽

Vol 7 (23) ◽

pp. 720-720 ◽

Author(s):

Linpei Jia ◽

Xingtong Dong ◽

Jingyan Yang ◽

Rufu Jia ◽

Hongliang Zhang

Keyword(s):

Systematic Review ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Meta Analysis ◽

Hypoxia Inducible Factor ◽

Prolyl Hydroxylase ◽

Renal Anemia ◽

Prolyl Hydroxylase Inhibitor

Download Full-text

Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors on iron regulation in non-dialysis-dependent chronic kidney disease patients with anemia: A systematic review and meta-analysis

Pharmacological Research ◽

10.1016/j.phrs.2020.105256 ◽

2020 ◽

pp. 105256

Author(s):

Jing Li ◽

Qiong-Hong Xie ◽

Li You ◽

Ning-Xin Xu ◽

Chuan-Ming Hao

Keyword(s):

Systematic Review ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Meta Analysis ◽

Hypoxia Inducible Factor ◽

Prolyl Hydroxylase ◽

Iron Regulation

Download Full-text

Effectiveness of hypoxia-induced factor prolyl hydroxylase inhibitor for managing anemia in chronic kidney disease: a systematic review and meta-analysis

European Journal of Clinical Pharmacology ◽

10.1007/s00228-020-03037-1 ◽

2020 ◽

Author(s):

Min Li ◽

Jiarong Lan ◽

Feixia Dong ◽

Peixin Duan

Keyword(s):

Systematic Review ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Meta Analysis ◽

Prolyl Hydroxylase ◽

Prolyl Hydroxylase Inhibitor

Download Full-text

In response to “Title: Letter to the Editor in response to the article ‘Efficacy and safety of HIF prolyl hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis’”

Pharmacological Research ◽

10.1016/j.phrs.2020.105227 ◽

2020 ◽

pp. 105227

Author(s):

Qiyan Zheng ◽

Huisheng Yang ◽

Yu Ning Liu ◽

Wei Jing Liu

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Meta Analysis ◽

Prolyl Hydroxylase ◽

Efficacy And Safety ◽

Letter To The Editor ◽

Prolyl Hydroxylase Inhibitor ◽

Hif Prolyl Hydroxylase

Download Full-text

Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis

Pharmacological Research ◽

10.1016/j.phrs.2020.105020 ◽

2020 ◽

Vol 159 ◽

pp. 105020 ◽

Author(s):

Qiyan Zheng ◽

Huisheng Yang ◽

Luying Sun ◽

Ruojun Wei ◽

Xinwen Fu ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Meta Analysis ◽

Prolyl Hydroxylase ◽

Efficacy And Safety ◽

Prolyl Hydroxylase Inhibitor ◽

Hif Prolyl Hydroxylase

Download Full-text

Long‐term efficacy and safety of hypoxia‐inducible factor prolyl hydroxylase inhibitors in anaemia of chronic kidney disease: A meta‐analysis including 13,146 patients

Journal of Clinical Pharmacy and Therapeutics ◽

10.1111/jcpt.13385 ◽

2021 ◽

Author(s):

Huanhuan Chen ◽

Qingfeng Cheng ◽

Jiuxiang Wang ◽

Xiaofang Zhao ◽

Shenyin Zhu

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Meta Analysis ◽

Hypoxia Inducible Factor ◽

Prolyl Hydroxylase ◽

Efficacy And Safety ◽

Download Full-text

Letter to the Editor in response to the article “Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis”

Pharmacological Research ◽

10.1016/j.phrs.2020.105213 ◽

2020 ◽

pp. 105213

Author(s):

Youssef M.K. Farag ◽

Zihe Zheng ◽

Wenli Luo

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Meta Analysis ◽

Prolyl Hydroxylase ◽

Efficacy And Safety ◽

Letter To The Editor ◽

Prolyl Hydroxylase Inhibitor ◽

Hif Prolyl Hydroxylase

Download Full-text

POS-285 EXPANDING THE POTENTIAL BENEFIT OF HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS FOR IMPROVING DYSLIPIDEMIA IN ANEMIA OF CHRONIC KIDNEY DISEASE PATIENTS: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Kidney International Reports ◽

10.1016/j.ekir.2021.03.300 ◽

2021 ◽

Vol 6 (4) ◽

pp. S121-S122

Author(s):

B.P. PUTRA ◽

F.N. Putra

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Randomized Controlled Trials ◽

Potential Benefit ◽

Meta Analysis ◽

Hypoxia Inducible Factor ◽

Prolyl Hydroxylase ◽

Controlled Trials ◽

Randomized Controlled

Download Full-text

Efficacy and safety of roxadustat for anaemia in dialysis‐dependent and non‐dialysis‐dependent chronic kidney disease patients: a systematic review and meta‐analysis

British Journal of Clinical Pharmacology ◽

10.1111/bcp.15055 ◽

2021 ◽

Author(s):

Li Zheng ◽

Jinhui Tian ◽

Deping Liu ◽

Yan Zhao ◽

Xiaoyong Fang ◽

...

Keyword(s):

Systematic Review ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Meta Analysis ◽

Efficacy And Safety

Download Full-text

Hypoxia-inducible factor prolyl hydroxylase inhibitor in the treatment of anemia in chronic kidney disease

Current Opinion in Nephrology & Hypertension ◽

10.1097/mnh.0000000000000617 ◽

2020 ◽

Vol 29 (4) ◽

pp. 414-422 ◽

Author(s):

Yu Kurata ◽

Tetsuhiro Tanaka ◽

Masaomi Nangaku

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Hypoxia Inducible Factor ◽

Prolyl Hydroxylase ◽

Prolyl Hydroxylase Inhibitor

Download Full-text